Scientific Data: In the SURPASS trials, tirzepatide showed higher rates of gastrointestinal side effects compared to semaglutide, but these were generally temporary and resolved as treatment continued
We invite you to discuss this innovative option with our experienced professionals to explore how it fits into your comprehensive weight loss and aesthetic journey
Retatrutide is primarily being studied for individuals with obesity and metabolic disorders, where traditional lifestyle interventions or single-agonist therapies may fall short
Step 7: Ongoing care Prescription-only patients receive limited follow-up, while VIP members get ongoing coaching, lifestyle guidance, and support from specialists
Try taking retatrutide with or immediately after breakfast and see if symptoms improve
Our providers guide and monitor your journey, helping you stay safe and accountable